- Home
- RAPT vs ONDS Comparison
RAPT vs ONDS Comparison
Compare RAPT & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- ONDS
- Stock Information
- Founded
- RAPT 2015
- ONDS 2014
- Country
- RAPT United States
- ONDS United States
- Employees
- RAPT N/A
- ONDS N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- ONDS Telecommunications Equipment
- Sector
- RAPT Health Care
- ONDS Telecommunications
- Exchange
- RAPT Nasdaq
- ONDS Nasdaq
- Market Cap
- RAPT 122.9M
- ONDS 326.8M
- IPO Year
- RAPT 2019
- ONDS N/A
- Fundamental
- Price
- RAPT $7.49
- ONDS $1.89
- Analyst Decision
- RAPT Buy
- ONDS Strong Buy
- Analyst Count
- RAPT 5
- ONDS 2
- Target Price
- RAPT $42.00
- ONDS $3.25
- AVG Volume (30 Days)
- RAPT 112.4K
- ONDS 24.8M
- Earning Date
- RAPT 08-07-2025
- ONDS 08-13-2025
- Dividend Yield
- RAPT N/A
- ONDS N/A
- EPS Growth
- RAPT N/A
- ONDS N/A
- EPS
- RAPT N/A
- ONDS N/A
- Revenue
- RAPT N/A
- ONDS $10,815,867.00
- Revenue This Year
- RAPT N/A
- ONDS $243.35
- Revenue Next Year
- RAPT N/A
- ONDS $113.88
- P/E Ratio
- RAPT N/A
- ONDS N/A
- Revenue Growth
- RAPT N/A
- ONDS N/A
- 52 Week Low
- RAPT $5.67
- ONDS $0.54
- 52 Week High
- RAPT $30.60
- ONDS $3.40
- Technical
- Relative Strength Index (RSI)
- RAPT 47.89
- ONDS 67.16
- Support Level
- RAPT $7.04
- ONDS $1.53
- Resistance Level
- RAPT $9.84
- ONDS $2.29
- Average True Range (ATR)
- RAPT 0.85
- ONDS 0.21
- MACD
- RAPT -0.05
- ONDS 0.01
- Stochastic Oscillator
- RAPT 33.55
- ONDS 60.22
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.